BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Saved in:
| Title: | BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial. |
|---|---|
| Authors: | Yao, Hao1,2,3,4 (AUTHOR) yaohao9001@163.com, Ren, Shi-hui1,2,3 (AUTHOR) 990057508@qq.com, Wang, Lin-hui5 (AUTHOR) 383002688@qq.com, Ren, Ming-qiang6 (AUTHOR) 844198637@qq.com, Cai, Jiao1,2,3 (AUTHOR) 2432556899@qq.com, Chen, Dan1,2,3 (AUTHOR) chendan286@163.com, He, Ying1,2,3 (AUTHOR) 891912585@qq.com, Lai, Si-han1,2,3 (AUTHOR) laisihan@163.com, Dou, Bai-tao1,2,3,7 (AUTHOR) 930695978@qq.com, Li, Meng-jiao1,2,3,7 (AUTHOR) 1848947330@qq.com, Li, Yan-ling1,2,3,7 (AUTHOR) 315803356@qq.com, Cen, Ya-li1,2,3 (AUTHOR) 2807276390@qq.com, Chang, Alex H.8,9 (AUTHOR) changah@yakebiotech.com, Su, Yi1,2,3 (AUTHOR) suhang1234@hotmail.com, Qiu, Ling1,2,3 (AUTHOR) 285066123@qq.com, Fan, Fang-yi1,2,3,7 (AUTHOR) 834525469@qq.com |
| Source: | Journal of Hematology & Oncology. 6/3/2025, Vol. 18 Issue 1, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
